ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

May 18, 2001

Clinical Nutrition Academic Award Concept Approved

October 4, 1985

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

November 8, 2002

ACCC Members Hear How Community Cancer Programs Are Developed

February 11, 1977

Congress Approves More Favorable Terms for Office-Administered Drugs

August 8, 1997

NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests

November 21, 1975